Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the effectiveness of buccal dextrose gel in preventing neonatal hypoglycaemia. It found that a single dose of 200 mg/kg dextrose gel significantly reduced the incidence of hypoglycaemia.
This randomized controlled trial investigated the effects of the dietary supplement EDC-HHA01 on metabolic health, finding significant reductions in HbA1c and insulin levels compared to placebo.
This study compared the effects of empagliflozin and pioglitazone on echocardiographic indices in patients with type 2 diabetes and nonalcoholic fatty liver disease, finding significant improvements in certain measures.
This study evaluated the addition of glargine, glimepiride, liraglutide, or sitagliptin to metformin in type 2 diabetes. It found varying rates of hypoglycemia among the different treatments.
This study followed adults at high risk of type 2 diabetes after a primary-care lifestyle programme in Poland. Among the 105 people with complete 3-year follow-up, many lost weight during the intervention and a smaller subgroup kept that weight off afterward. Because there was no concurrent control group in this analysis, the findings should be interpreted cautiously.
This study investigated the effects of magnesium oxide supplementation on glycemic control in older adults with pre-diabetes and hypomagnesemia, finding a significant reduction in fasting plasma glucose.
This study evaluated the effects of Melissa officinalis extract on depression and anxiety in patients with type 2 diabetes, finding significant reductions in both conditions.
This study explored factors influencing engagement with the i-Matter mHealth tool for diabetes self-management, highlighting its impact on patient attitudes and engagement.
This study investigated the effects of the MIND diet on cardiometabolic health in women with type 2 diabetes and insomnia, finding significant reductions in various health markers.
This Phase 3 trial evaluated a novel semaglutide injection in Indian adults with Type 2 diabetes, showing significant reductions in HbA1c and body weight.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
